Skip to main content

Want a detailed portfolio tracker?

Comparison Iterum Therapeutics (ITRM) with Competitors

Iterum Therapeutics (ITRM) industry is Biotechnology.

Debt-to-Equity
ITRM-271.58%
Industry28.27%
Upside-299.84%
P/E
ITRM-0.22
Industry-20.52
Upside+2029.91%